Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic par...
Những tác giả chính: | Aveyard, P, Parsons, A, Begh, R |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2009
|
Những quyển sách tương tự
-
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
Bằng: Kacper Więcław, et al.
Được phát hành: (2023-08-01) -
The place of varenicline in smoking cessation treatment.
Bằng: Aveyard, P
Được phát hành: (2008) -
Smoking cessation 4: Antidepressants for smoking cessation - Bupropion and nortriptyline
Bằng: Aveyard, P, et al.
Được phát hành: (2010) -
Placebo-controlled trial of cytisine for smoking cessation.
Bằng: West, R, et al.
Được phát hành: (2011) -
Nicotine receptor partial agonists for smoking cessation
Bằng: Livingstone-Banks, J, et al.
Được phát hành: (2023)